The Global Market for Stem Cells

March 2018 | 162 pages | ID: GAD794B4A51EN
BCC Research

Abstracts

Report Scope:

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed, with profiles of the leading companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved.

Report Includes:

• 42 data tables and 18 additional tables
• An overview of the global market for stem cells
• Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Identification of segments with high growth potential and their future applications
• Explanation of major drivers and regional dynamics of the market and current trends within the industry
• Detailed profiles of major vendors in the market, including Cellular Dynamics International, Inc., Celyad, Cytori Therapeutics, Inc., Epistem Ltd. and Gamida-Cell Ltd.

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
Market Analyses and Forecasts
Methodology
Intended Audience
Information Sources
Analyst's Credentials
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

Definitions
Applications
Research and Commercialization
Funding
Market

CHAPTER 3 OVERVIEW

Cells
Stem Cells
Induced Pluripotent Stem Cells

CHAPTER 4 STEM CELL RESEARCH

History
Embryonic Stem Cells
Growth and Identification of Embryonic Stem Cells
Stimulating Embryonic Stem Cells to Differentiate
Adult Stem Cells
Mesechymal Stem Cells
Hematopoietic Stem Cells
Neural Stem Cell
Endothelial Progenitor Cell
Epithelial Stem Cell
Very Small Embryonic-Like Cell
Cord Blood Stem Cells
Induced Pluripotent Stem Cells
Nuclear Reprogramming
Cell-Based Therapeutics
Embryonic-Derived Stem Cells
Adult and Progenitor-Derived Stem Cells
Engineered Stem Cells for Transplantation
Therapeutic Stem Cell Banking
Stem-Cell-Based Biomedical Research
Stem Cell Research Centers
Regulation of Stem Cell Research
National Regulatory Measures
Practicalities of Stem Cell Research and Production
Stem Cell Production
Stem Cell Acquisition
Stem Cell Production Economics
Customized Therapy
Banks
Novel Stem Cell Production Developments
Isolation and Engineering
Adult Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells
Bioprinting
Stem Cell Banking

CHAPTER 5 STEM CELL APPLICATIONS

Regenerative Medicine
Current Stem Cell Therapy Applications
Cancer
Amyotrophic Lateral Sclerosis
Parkinson's Disease
Spinal Cord Injury
Alzheimer's Disease
Heart Disease
Peripheral Arterial Disease
Type 1 Diabetes
Orthopedic Repair
Liver Failure
Graft-Versus-Host Disease
Lung Disease

CHAPTER 6 STEM CELL PATENTS

General Background on Patents
Stem Cell Patents
Policies by Country
U.S
Canada
EPC
U.K.
Germany
Japan
China
Induced Pluripotent Stem Cells
Recent Patent Activity

CHAPTER 7 STEM CELL MARKETS

Markets for Stem Cells
Market Drivers
Market Opportunities by Therapeutic Class
Cancer
Cardiovascular Disease
Myocardial Infarction
Central Nervous System Disease
Spinal Cord Injury
Neurodegenerative Diseases
Diabetes Mellitus
Skeletal System
Global Market Estimates and Forecasts
Regional and National Market Analysis
Americas
U.S.
Canada
Brazil
Mexico
Europe
France
Germany
Italy
Spain
U.K.
Asia-Pacific
Market Opportunities by Disease Category
Japan
China
India
Rest of World

CHAPTER 8 COMPANY PROFILES

3DMATRIX
ALDAGEN INC.
ARTERIOCYTE
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD
BIOTIME INC.
BRAINSTORM CELL THERAPEUTICS INC.
CALADRIUS BIOSCIENCES INC.
CAPRICOR INC.
CELLERANT THERAPEUTICS INC.
CELLULAR DYNAMICS INTERNATIONAL
CELYAD
CYTORI THERAPEUTICS INC.
EPISTEM LTD.
GAMIDA CELL LTD.
GLOBALSTEM
HYBRID ORGAN GMBH
INTERNATIONAL STEM CELL CORPORATION
JUVENTAS THERAPEUTICS INC.
MESOBLAST LTD.
NEUROGENERATION
OCATA
OSIRIS THERAPEUTICS INC.
PRIMEGEN BIOTECH LLC
RENEURON GROUP
RHINOCYTE INC.
STEM CELLS INC.
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS
TIGENIX NV
U.S. STEM CELL INC.
VERICEL CORPORATION
VERISTEM
VIACYTE INC.
VITRO DIAGNOSTICS INC.
WICELL RESEARCH INSTITUTE
XPAND BIOTECHNOLOGY BV

CHAPTER 9 APPENDIX 1: GLOSSARY

CHAPTER 10 APPENDIX 2: SIGNIFICANT STEM CELL RESEARCH PATENTS

List Of Tables

LIST OF TABLES

Summary Table: Global Stem Cell Market, by Region, Through 2022
Table 1: Bioprinting Emerging Platforms
Table 2: Table 2 Countries Engaged in the ISCBI Program, 2017
Table 3: Yamanaka’s Induced Pluripotent Stem-Related Patents, 2011
Table 4: Stem Cell Patents, by Type, 2011
Table 5: Global Healthcare Systems, 2017
Table 6: Companies Developing Stem Cell Therapies for Cardiovascular Diseases, 2017
Table 7: U.S. Statistics for Spinal Cord Injury, 2017
Table 8: Global Neurodegenerative Diseases, 2015
Table 9: U.S. Statistics for Diabetes, 2015
Table 10: Global Market for Diabetes Mellitus, Treatments and Devices, Through 2022
Table 11: Global Stem Cell Market, by Region, Through 2022
Table 12: Stem Cell Market, by Country, Through 2022
Table 13: Potential U.S. Patient Populations for Cell-Based Therapies, 2016
Table 14: U.S. Stem Cell Therapy Market, Through 2022
Table 15: U.S. Stem Cell Research and Services Market, Through 2022
Table 16: U.S. Stem Cell Cord Blood Services Market, Through 2022
Table 17: Canadian Stem Cell Therapy Market, Through 2022
Table 18: Canadian Stem Cell Research and Services Market, Through 2022
Table 19: Canadian Stem Cell Cord Blood Services Market, Through 2022
Table 20: Brazilian Stem Cell Therapy Market, Through 2022
Table 21: Brazilian Stem Cell Research and Services Market, Through 2022
Table 22: Brazilian Stem Cell Cord Blood Services Market, Through 2022
Table 23: Mexican Stem Cell Therapy Market, Through 2022
Table 24: Mexican Stem Cell Cord Blood Services Market, Through 2022
Table 25: European Stem Cell Market, by Country, Through 2022
Table 26: European Statistics for Cardiovascular Disease, 2017
Table 27: European Rate of Death from Heart Disease, by Country, 2016
Table 28: European Statistics for Central Nervous System Disorders and Injuries, 2016
Table 29: European Statistics for Spinal Cord Injury and Parkinson’s Disease, by Country, 2016
Table 30: European Prevalence of Diabetic Patients, by Country, 2017
Table 31: French Stem Cell Therapy Market, Through 2022
Table 32: French Stem Cell Research and Services Market, Through 2022
Table 33: French Stem Cell Cord Blood Services Market, Through 2022
Table 34: German Stem Cell Therapy Market, Through 2022
Table 35: German Stem Cell Research and Services Market, Through 2022
Table 36: German Stem Cell Cord Blood Services Market, Through 2022
Table 37: Italian Stem Cell Therapy Market, Through 2022
Table 38: Italian Stem Cell Research and Services Market, Through 2022
Table 39: Italian Stem Cell Cord Blood Services Market, Through 2022
Table 40: Spanish Stem Cell Therapy Market, Through 2022
Table 41: Spanish Stem Cell Research and Services Market, Through 2022
Table 42: Spanish Stem Cell Cord Blood Services Market, Through 2022
Table 43: U.K. Stem Cell Therapy Market, Through 2022
Table 44: U.K. Stem Cell Research and Services Market, Through 2022
Table 45: U.K. Stem Cell Cord Blood Services Market, Through 2022
Table 46: China and India Statistics for Cardiovascular Disease, 2016
Table 47: Asia-Pacific Stem Cell Policies, 2017
Table 48: Asia-Pacific Stem Cell Market, by Country, Through 2022
Table 49: Japanese Stem Cell Therapy Market, Through 2022
Table 50: Japanese Stem Cell Research and Services Market, Through 2022
Table 51: Japanese Stem Cell Cord Blood Services Market, Through 2022
Table 52: Chinese Stem Cell Therapy Market, Through 2022
Table 53: Chinese Stem Cell Research and Services Market, Through 2022
Table 54: Chinese Stem Cell Cord Blood Services Market, Through 2022
Table 55: Potential Candidates for Stem Cell Therapy in India, 2016
Table 56: Indian Stem Cell Therapy Market, Through 2022
Table 57: Indian Stem Cell Research and Services Market, Through 2022
Table 58: Indian Stem Cell Cord Blood Services Market, Through 2022
Table 59: Stem Cell Market in the Rest of the World, Through 2022

List Of Figures

LIST OF FIGURES

Summary Figure: Global Stem Cell Market, by Region, 2015–2022
Figure 1: Early Development of Embryo